Brochure for INFORCE 3 - Dairy Wellness
Brochure for INFORCE 3 - Dairy Wellness
Brochure for INFORCE 3 - Dairy Wellness
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
BRSV can be prevented.<br />
<strong>INFORCE</strong> 3 is the first and only respiratory vaccine to be<br />
granted the “prevention of disease” indication, the highest<br />
label claim available <strong>for</strong> BRSV protection.<br />
100%<br />
90%<br />
100%<br />
80%<br />
% Mortality<br />
60%<br />
40%<br />
20%<br />
0%<br />
0% 0%<br />
3- to 9-dayold<br />
calves *<br />
6- to 8-weekold<br />
calves *<br />
<strong>INFORCE</strong> 3 = NO DEATHS<br />
All <strong>INFORCE</strong> 3 vaccinates survived<br />
severe BRSV challenges, while almost<br />
all unvaccinated controls died. 10,11<br />
(P–< 0.0001) (P – 0.0001)<br />
<strong>INFORCE</strong> 3 Control<br />
60%<br />
57.6%<br />
% Lung Damage<br />
40%<br />
20%<br />
0%<br />
13.5%<br />
43.8%<br />
3- to 9-dayold<br />
calves *<br />
5.8%<br />
6- to 8-weekold<br />
calves *<br />
<strong>INFORCE</strong> 3 = LESS LUNG DAMAGE<br />
Fewer lung lesions due to BRSV<br />
infections mean <strong>INFORCE</strong> 3 vaccinates<br />
should be expected to require reduced<br />
labor and treatment costs, and<br />
improved productivity. 9,10<br />
(P=0.0006)<br />
(P
Change language